Cell Therapy Manufacturing Is Hitting a Scalabilit..

Criou um novo artigo

1 C

Cell Therapy Manufacturing Is Hitting a Scalability Wall And Most Companies Are Unprepared | #market&Minds

Cell Therapy Manufacturing Is Hitting a Scalability Wall And Most Companies Are Unprepared

Cell Therapy Manufacturing Is Hitting a Scalability Wall And Most Companies Are Unprepared

The promise of personalized medicine is colliding with industrial reality. As CAR-T therapies and regenerative treatments move from clinical trials to commercial scale, manufacturers are discovering that manual processing methods cannot support the volume, consistency, or economics require

Curtir

Comentario

Compartilhar